UCSF’s Dr. Michael Matthay wasn’t thinking about a pandemic in January when he launched a clinical trial to investigate whether certain stem cells could effectively treat a serious form of respiratory failure.
Then the coronavirus came to the United States. Now, most of the people who are part of the trial Matthay is leading in San Francisco and other locations have COVID-19, the disease caused by the virus. Many patients with severe cases of COVID-19 develop acute respiratory distress syndrome, or ARDS, which was the impetus for Matthay’s study. ARDS is often caused by pneumonia but can also be triggered by other critical illnesses or major injuries. (SFChronicle.com)